Immunohistochemical analysis revealed that p-tau immunoreactivity was predominantly in the ITGC and was higher in AD patients (NBB no. 00119; Autopsy S00/264) compared to control subjects (NBB no. 01045; Autopsy S01/115). Here, MAPT is linked to Alzheimer disease.